WEE1 and melanoma: Adavosertib (previously named AZD-1775) is a pyrazolo-pyrimidine derivative, acting as an ATP competitive potent and selective small molecule inhibitor of WEE1, and displays cytotoxic activity as a single agent in many cancer cell lines, including melanoma cells [83,129,130].